Sichuan Biokin Pharmaceutical Co.,Ltd. (SHA:688506)

SHA:688506 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 16, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	119,097	76,884	56,100	-	-	-
Market Cap Growth	37.05%	37.05%	-	-	-	-
Enterprise Value	115,412	73,458	56,019	-	-	-
Last Close Price	297.00	191.73	139.90	-	-	-
PE Ratio	32.11	20.74	-	-	-	-
Forward PE	-	71.91	-	-	-	-
PS Ratio	20.45	13.20	99.85	-	-	-
PB Ratio	30.65	19.79	369.39	-	-	-
P/TBV Ratio	30.86	19.92	452.87	-	-	-
P/FCF Ratio	29.96	19.34	-	-	-	-
P/OCF Ratio	29.34	18.94	-	-	-	-
EV/Sales Ratio	19.82	12.62	99.70	-	-	-
EV/EBITDA Ratio	30.65	19.57	-	-	-	-
EV/EBIT Ratio	31.31	19.93	-	-	-	-
EV/FCF Ratio	29.04	18.48	-	-	-	-
Debt / Equity Ratio	0.53	0.53	4.53	0.59	0.87	0.33
Debt / EBITDA Ratio	0.55	0.55	-	-	-	5.68
Debt / FCF Ratio	0.52	0.52	-	-	-	2.38
Asset Turnover	1.36	1.36	0.33	0.48	0.80	0.95
Inventory Turnover	1.87	1.87	2.00	2.59	2.75	2.82
Quick Ratio	2.99	2.99	0.52	1.73	0.62	0.89
Current Ratio	3.19	3.19	0.74	1.94	0.90	1.07
Return on Equity (ROE)	183.64%	183.64%	-143.77%	-44.62%	-25.51%	8.62%
Return on Assets (ROA)	53.82%	53.82%	-28.74%	-14.01%	-10.00%	-1.34%
Return on Capital (ROIC)	67.82%	67.82%	-42.30%	-19.63%	-16.33%	-2.33%
Return on Capital Employed (ROCE)	71.50%	71.50%	-	-	-	-
Earnings Yield	3.11%	4.82%	-1.39%	-	-	-
FCF Yield	3.34%	5.17%	-1.24%	-	-	-
Payout Ratio	1.03%	1.03%	-	-	-	26.28%
Buyback Yield / Dilution	-0.14%	-0.14%	-10.56%	-1.38%	-3.64%	10.86%
Total Shareholder Return	-	-0.14%	-10.56%	-1.38%	-3.64%	10.86%

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.